Immunizations for HIV-Infected Adults

Overview

CME Credit Available: 1.50 AMA PRA Category 1 Credits
Level: Advanced
Release Date: July 13, 2017
Date of Last Review/Update: June 9, 2017
Expiration Date: July 13, 2018

This Cases on the Web (COW) activity focuses on the immunization requirements of a 26-year-old man with HIV infection and explores specific vaccines and their administration based on his age, immunologic status, and assessed risk. Guidance for immunizations appropriate for international travel are also discussed.

At each decision point, participants should select the option that they think is most sound and then read the presenters’ explanation of that option. Selecting the correct option links the participant to an extended discussion of the related medical findings, research-based evidence, and case management considerations.

To advance from one clinical decision point to the next, participants should click on the NEXT button located at the bottom of the page that discusses the best clinical option.

After reviewing the cases, participants may access the activity posttest and the course evaluation, both of which must be completed and submitted to claim continuing medical education (CME) credit or a certificate of participation or continuing education units (CEUs) or nursing or pharmacy credits. Please see the posttest form and course evaluation form for further instructions.

Learning Objectives

On completion of this activity, learners will be able to:

  • List the recommended immunizations for adults living with HIV infection
  • Provide specific immunization guidance based on an individual’s immunologic status and assessed risk
  • Identify contraindications to specific immunizations for persons with substantial immune deficiency
  • Identify interactions among vaccines that may impact the timing of vaccine administration
  • Provide guidance regarding immunizations appropriate for persons with HIV infection who are travelling internationally

Assessment of Needs

The IAS–USA offers this state-of-the-art activity as part of a nationwide CME effort for physicians on the evolving challenges of managing HIV disease. This activity examines the immunization needs and considerations for adults living with HIV infection.

Intended Audience

This enduring material is designed for physicians who are actively treating or will be treating patients with HIV infection. This activity is also relevant for other practitioners, including nurse practitioners, nurses, physician assistants, pharmacists, and others.

CME Information

Accreditation

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The IAS–USA designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is offered from July 13, 2017 to July 13, 2018. Physicians (MDs, DOs, and international equivalents) who successfully complete the activity posttest and submit the evaluation and registration forms are eligible to receive CME credit. Other health care practitioners will receive a Certificate of Participation.

Pharmacy Continuing Education Contact Hours

Accreditation Council for Pharmacy Education logoEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.5 hours (0.15 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
UAN # 0761-9999-17-245-H02-P

Program expires 7/12/2019.

Nursing Continuing Education Contact Hours

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 1.5 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Program expires 7/12/2019.

Faculty

Author

Brian T. Montague, DO, MS, MPH
Dr Montague is a fellow in the Division of Infectious Diseases at University of Colorado School of Medicine in Aurora, Colorado. He was previously Director of Ryan White HIV/AIDS Program care services at Miriam Hospital in Providence, Rhode Island. His research interests include linkage to care and retention in care for individuals living with HIV/AIDS as well as strategies to improve uptake to treatment for individuals with hepatitis C virus infection.

Steven C. Johnson, MD
Dr Johnson is Professor of Medicine and Associate Division Head for Clinical Affairs in the Division of Infectious Diseases, and Director of the HIV/AIDS Clinical Program at University of Colorado School of Medicine in Aurora, Colorado.

Editor

Howard Libman, MD
Dr Libman is Professor of Medicine at Harvard Medical School and Director of the HIV Program of Healthcare Associates at Beth Israel Deaconess Medical Center in Boston, Massachusetts.

Disclosure of Financial Interest With Commercial Concerns

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education, the IAS–USA requires all persons with control of content (eg, course faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the previous 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

Faculty

Drs Montague and Johnson have no relevant financial affiliations to disclose (Updated 6/28/17).

Editor

Dr Libman receives salary support from Beth Israel Deaconess Medical Center in Boston, Massachusetts, and from UpToDate. (Updated 6/14/17)

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

For our HIV effort

  • PLATINUM SUPPORTER
    ViiV Healthcare
  • GOLD SUPPORTER
    Gilead Sciences, Inc
  • SILVER SUPPORTERS
    Bristol-Myers Squibb
    Janssen Therapeutics
  • BRONZE SUPPORTER
    Merck

For our viral hepatitis effort

  • GOLD SUPPORTERS
    Gilead Sciences, Inc
    Merck
  • BRONZE SUPPORTER
    AbbVie

Cases on the Web Editorial Board

Members of the COW Editorial Board participate in a volunteer capacity. They are not compensated for their role in overseeing the program. Listed below are the COW Editorial Board members and their financial interests with commercial companies within the past 12 months from the date of disclosure. Click here to view the COW Editorial Board.

Drug and Product Disclaimer

This activity may contain information about the investigational uses of drugs or products that are not approved by the US Food and Drug Administration. Please consult full prescribing information before using any medication or product mentioned in this COW activity.

The views and opinions expressed herein are those of the faculty and do not necessarily represent the opinions or recommendations of the IAS–USA.

Contact Information

If you have any questions about this COW activity, please contact the IAS–USA:

IAS–USA
425 California St
Ste 1450
San Francisco, CA 94104-2120
Telephone: 415-544-9400
Fax: 415-544-9401
E-mail: info“at”iasusa.org